medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2021, Number S1

<< Back Next >>

Acta Med 2021; 19 (S1)

Cutaneous manifestations secondary to the COVID-19 pandemic

García ACB, Adame MG, Aguilar MR, Arias GMI, Carbajosa MJ, Miranda GA, Muñoz HH

Language: Spanish
References: 50
Page: s27-36
PDF size: 254.40 Kb.


ABSTRACT

In the medical literature, the skin reactions related to the acute respiratory distress syndrome have been fully described. There are few reports of the skin diseases indirectly related to the pandemic, which have increased in incidence. This review focuses on skin problems related with COVID-19, including adverse drug reaction to its treatments, personal protective equipment skin reactions and secondary cutaneous involvements due to circumstances during the pandemic, including acne, rosacea, seborrheic dermatitis and herpes zoster.


REFERENCES

  1. Galván Casas C, Catalá A, Carretero Hernández G, Rodríguez-Jiménez P, Fernández-Nieto D, Rodríguez-Villa Lario A et al. Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases. Br J Dermatol. 2020; 183 (1): 71-77. doi: 10.1111/bjd.19163.

  2. Su CJ, Lee CH. Viral exanthem in COVID-19, a clinical enigma with biological significance. J Eur Acad Dermatol Venereol. 2020; 34 (6): e251-e252. doi: 10.1111/jdv.16469.

  3. Freeman EE, McMahon DE, Lipoff JB, Rosenbach M, Kovarik C, Desai SR et al. The spectrum of COVID-19-associated dermatologic manifestations: An international registry of 716 patients from 31 countries. J Am Acad Dermatol. 2020; 83 (4): 1118-1129. doi: 10.1016/j.jaad.2020.06.1016.

  4. Suchonwanit P, Leerunyakul K, Kositkuljorn C. Cutaneous manifestations in COVID-19: Lessons learned from current evidence. J Am Acad Dermatol. 2020; 83 (1): e57-e60. doi: 10.1016/j.jaad.2020.04.094.

  5. Litt JZ. Drug eruption reference manual. Including drug interactions. 10th edition. New York: CRP Press; 2004.

  6. Honda H, Iwata K. Personal protective equipment and improving compliance among healthcare workers in high-risk settings. Curr Opin Infect Dis. 2016; 29 (4): 400-406. doi: 10.1097/QCO.0000000000000280.

  7. Yan Y, Chen H, Chen L, Cheng B, Diao P, Dong L et al. Consensus of Chinese experts on protection of skin and mucous membrane barrier for health-care workers fighting against coronavirus disease 2019. Dermatol Ther. 2020; 33 (4): e13310. doi: 10.1111/dth.13310.

  8. Bhatia R, Sindhuja T, Bhatia S, Dev T, Gupta A, Bajpai M et al. Iatrogenic dermatitis in times of COVID-19: a pandemic within a pandemic. J Eur Acad Dermatol Venereol. 2020; 34 (10): e563-e566. doi: 10.1111/jdv.16710.

  9. Guertler A, Moellhoff N, Schenck TL, Hagen CS, Kendziora B, Giunta RE et al. Onset of occupational hand eczema among healthcare workers during the SARS-CoV-2 pandemic: comparing a single surgical site with a COVID-19 intensive care unit. Contact Dermatitis. 2020; 83 (2): 108-114. doi: 10.1111/cod.13618.

  10. Desai SR, Kovarik C, Brod B, James W, Fitzgerald ME, Preston A et al. COVID-19 and personal protective equipment: Treatment and prevention of skin conditions related to the occupational use of personal protective equipment. J Am Acad Dermatol. 2020; 83 (2): 675-677. doi: 10.1016/j.jaad.2020.05.032.

  11. Hadjieconomou S, Hughes J, Kamath S. Occupational skin disease during the COVID-19 pandemic, as captured in a Dermatology staff clinic in the United Kingdom. J Eur Acad Dermatol Venereol. 2020; 34 (11): e670-e671. doi: 10.1111/jdv.16754.

  12. Elston DM. Occupational skin disease among health care workers during the coronavirus (COVID-19) epidemic. J Am Acad Dermatol. 2020; 82 (5): 1085-1086. doi: 10.1016/j.jaad.2020.03.012.

  13. Erickson MM, Richardson ES, Hernandez NM, Bobbert DW 2nd, Gall K, Fearis P. Helmet modification to PPE with 3D printing during the COVID-19 pandemic at duke university medical center: a novel technique. J Arthroplasty. 2020; 35 (7S): S23-S27. doi: 10.1016/j.arth.2020.04.035.

  14. Long H, Zhao H, Chen A, Yao Z, Cheng B, Lu Q. Protecting medical staff from skin injury/disease caused by personal protective equipment during epidemic period of COVID-19: experience from China. J Eur Acad Dermatol Venereol. 2020; 34 (5): 919-921. doi: 10.1111/jdv.16388.

  15. Zhou NY, Yang L, Dong LY, Li Y, An XJ, Yang J et al. Prevention and treatment of skin damage caused by personal protective equipment: experience of the first-line clinicians treating 2019-nCoV infection. International Journal of Dermatology and Venereology. 2020: 10.1097/JD9.0000000000000085. doi: 10.1097/JD9.0000000000000085. [Published on line]

  16. Kownatzki E. Hand hygiene and skin health. J Hosp Infect. 2003; 55 (4): 239-245. doi: 10.1016/j.jhin.2003.08.018.

  17. Larson E, Friedman C, Cohran J, Treston-Aurand J, Green S. Prevalence and correlates of skin damage on the hands of nurses. Heart Lung. 1997; 26 (5): 404-412. doi: 10.1016/s0147-9563(97)90027-3.

  18. Veraldi S, Angileri L, Barbareschi M. Seborrheic dermatitis and anti-COVID-19 masks. J Cosmet Dermatol. 2020; 19 (10): 2464-2465. doi: 10.1111/jocd.13669.

  19. Han C, Shi J, Chen Y, Zhang Z. Increased flare of acne caused by long-time mask wearing during COVID-19 pandemic among general population. Dermatol Ther. 2020; 33 (4): e13704. doi: 10.1111/dth.13704.

  20. Giacalone S, Minuti A, Spigariolo CB, Passoni E, Nazzaro G. Facial dermatoses in the general population due to wearing of personal protective masks during the COVID-19 pandemic: first observations after lockdown. Clin Exp Dermatol. 2021; 46 (2): 368-369. doi: 10.1111/ced.14376.

  21. Zuo Y, Hua W, Luo Y, Li L. Skin reactions of N95 masks and medial masks among health-care personnel: A self-report questionnaire survey in China. Contact Dermatitis. 2020; 83 (2): 145-147. doi: 10.1111/cod.13555.

  22. Albuquerque RG, Rocha MA, Bagatin E, Tufik S, Andersen ML. Could adult female acne be associated with modern life? Arch Dermatol Res. 2014; 306 (8): 683-688. doi: 10.1007/s00403-014-1482-6.

  23. Dréno B, Layton A, Zouboulis CC, López-Estebaranz JL, Zalewska-Janowska A, Bagatin E et al. Adult female acne: a new paradigm. J Eur Acad Dermatol Venereol. 2013; 27 (9): 1063-1070. doi: 10.1111/jdv.12061.

  24. Saldaña M, Fierro-Arias L. Acné y depresión. Dermatol Rev Mex. 2019; 63 (Suppl: 1): 18-24.

  25. Bowe WP. Could probiotics be the next big thing in acne and rosacea treatments, Schaumburg, IL: Interview with the American Academy of Dermatology: 2014. Retrieved from: https://www.aad.org/stories-and-news/news-releases/could-probiotics-be-the-next-big-thing-in-acne-and-rosacea-treatments

  26. Bowe WP. Probiotics in acne and rosacea. Cutis. 2013; 92 (1): 6-7.

  27. Baquerizo Nole KL, Yim E, Keri JE. Probiotics and prebiotics in dermatology. J Am Acad Dermatol. 2014; 71 (4): 814-821. doi: 10.1016/j.jaad.2014.04.050.

  28. Cardwell LA, Alinia H, Moradi Tuchayi S, Feldman SR. New developments in the treatment of rosacea - role of once-daily ivermectin cream. Clin Cosmet Investig Dermatol. 2016; 9: 71-77. doi: 10.2147/CCID.S98091.

  29. Holmes AD. Potential role of microorganisms in the pathogenesis of rosacea. J Am Acad Dermatol. 2013; 69 (6): 1025-1032. doi: 10.1016/j.jaad.2013.08.006.

  30. Martín JM, Pellicer Z, Bella R, Jordá E. Rosácea desencadenada por un complejo vitamínico del grupo B. Actas Dermosifiliogr. 2011; 102 (3): 223-224. doi: 10.1016/j.ad.2010.06.028.

  31. Arias MI. Rosácea y dieta. En: Kaminsky A, Piquero JM, Herane MI, Diez de Medina JC, Flórez-White M. Rosácea, una visión integral. Buenos Aires: GILER; 2018. Cap. 33: pp. 374-377.

  32. Sampaio AL, Mameri AC, Vargas TJ, Ramos-e-Silva M, Nunes AP, Carneiro SC. Seborrheic dermatitis. An Bras Dermatol. 2011; 86 (6): 1061-1071; quiz 1072-1074. doi: 10.1590/s0365-05962011000600002.

  33. Clark GW, Pope SM, Jaboori KA. Diagnosis and treatment of seborrheic dermatitis. Am Fam Physician. 2015; 91 (3): 185-190.

  34. Del Rosso JQ. Adult seborrheic dermatitis: a status report on practical topical management. J Clin Aesthet Dermatol. 2011; 4 (5): 32-38.

  35. Dessinioti C, Katsambas A. Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies. Clin Dermatol. 2013; 31 (4): 343-351. doi: 10.1016/j.clindermatol.2013.01.001.

  36. Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig Dermatol. 2015; 3 (2): 10.13188/2373-1044.1000019. doi: 10.13188/2373-1044.1000019.

  37. Medina Castillo DE. Dermatitis seborreica: una revisión. DCMQ. 2014; 12 (2): 135-140.

  38. Reider N, Fritsch PO. Otras erupciones eccematosas. En: Bolognia JL, editor. Dermatología. 4ª ed. España: Elsevier; 2018. Cap. 13: pp. 228-232.

  39. Yawn BP, Gilden D. The global epidemiology of herpes zoster. Neurology. 2013; 81 (10): 928-930.

  40. Cohen JI. Clinical practice: herpes zoster. N Engl J Med. 2013; 369 (3): 255-263. doi: 10.1056/NEJMcp1302674.

  41. Saati A, Al-Husayni F, Malibari AA, Bogari AA, Alharbi M. Herpes zoster co-infection in an immunocompetent patient with COVID-19. Cureus. 2020; 12 (7): e8998. doi: 10.7759/cureus.8998.

  42. Wung PK, Holbrook JT, Hoffman GS, Tibbs AK, Specks U, Min YI et al. Herpes zoster in immunocompromised patients: incidence, timing, and risk factors. Am J Med. 2005; 118 (12): 1416. doi: 10.1016/j.amjmed.2005.06.012.

  43. Kawai K, Yawn BP. Risk factors for herpes zoster: a systematic review and meta-analysis. Mayo Clin Proc. 2017; 92 (12): 1806-1821. doi: 10.1016/j.mayocp.2017.10.009.

  44. Elsaie ML, Youssef EA, Nada HA. Herpes zoster might be an indicator for latent COVID 19 infection. Dermatol Ther. 2020; 33 (4): e13666. doi: 10.1111/dth.13666.

  45. Shors AR. Herpes zoster and severe acute herpetic neuralgia as a complication of COVID-19 infection. JAAD Case Rep. 2020; 6 (7): 656-657. doi: 10.1016/j.jdcr.2020.05.012.

  46. Ferreira ACAF, Romão TT, Macedo YS, Pupe C, Nascimento OJM; Fellow of the American Academy of Neurology (FAAN). COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy. Eur J Neurol. 2020; 27 (9): 1748-1750. doi: 10.1111/ene.14361.

  47. Schmader K. Herpes zoster. Ann Intern Med. 2018; 169 (3): ITC19-ITC31. doi: 10.7326/AITC201808070.

  48. Zheng M, Gao Y, Wang G, Song G, Liu S, Sun D et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020; 17 (5): 533-535. doi: 10.1038/s41423-020-0402-2.

  49. Xu R, Zhou Y, Cai L, Wang L, Han J, Yang X et al. Co-reactivation of the human herpesvirus alpha subfamily (herpes simplex virus-1 and varicella zoster virus) in a critically ill patient with COVID-19. Br J Dermatol. 2020; 183 (6): 1145-1147. doi: 10.1111/bjd.19484.

  50. Lan J, Song Z, Miao X, Li H, Li Y, Dong L et al. Skin damage among health care workers managing coronavirus disease-2019. J Am Acad Dermatol. 2020; 82 (5): 1215-1216. doi: 10.1016/j.jaad.2020.03.014.




2020     |     www.medigraphic.com